
Hassan’s practice focuses on advising a broad range of clients—including health plans, pharmacy benefit managers, rebate aggregators, providers, and private equity firms—in contract negotiations, complex industry transactions, and compliance and regulatory matters. He regularly counsels plans, PBMs, rebate aggregators, and providers on regulatory, operational and contracting matters; and often advises clients on compliance with the anti-kickback statute and corporate practice of medicine prohibitions.
Hassan leverages his prior experience representing private equity firms in various acquisitions, restructurings, and growth equity transactions to provide reasoned and pragmatic solutions to a wide range of client needs.
Prior to joining Mintz, Hassan was an associate with a large, international law firm in New York City, and then later, with a boutique law firm in Los Angeles.
Hassan received his J.D. from Duke Law School, where he was an editor of the Duke Journal of Constitutional Law and Public Policy. He received his B.S.Ed and MPH from Baylor University, with a concentration in health education.
viewpoints
Mintz IRA Update — Inaugural Edition
September 20, 2023 | Blog | By Theresa Carnegie, Tara E. Dwyer, Mitchell Clough, Xavier Hardy, Stephnie John, Bridgette Keller, Lauren Moldawer, Pat Ouellette, Hassan Shaikh
Mintz Health Law: What We Are Grateful For
January 11, 2023 | Podcast | By Bridgette Keller
PBM Regulatory Roundup (Fall 2022): State Medicaid Enforcement Efforts Continue As Legislative Activity Slows Down
November 14, 2022 | Blog | By Bridgette Keller, Hassan Shaikh
MintzRx Newsletter — Your Prescription for the Pharmaceutical Supply Chain
October 3, 2022 | Article | By Theresa Carnegie, Tara E. Dwyer, Xavier Hardy, Stephnie John, Bridgette Keller, Lauren Moldawer, Pat Ouellette, Hassan Shaikh
PBM Regulatory Roundup (Summer 2022): States Continue PBM Oversight Activities
August 2, 2022 | Blog | By Bridgette Keller, Hassan Shaikh, Derek Flynn, Shaina Sikka
PBMs Continue to Draw Federal Scrutiny: PBM Transparency Act of 2022
June 30, 2022 | Blog | By Bridgette Keller, Hassan Shaikh, Sergey Smirnov, Jewel Duberry-Douglas
At the same time, government watchdogs are also taking action: on June 7, 2022, the FTC announced that it would launch an inquiry into vertically integrated PBMs, and the Office of the Inspector General (OIG) for the Department of Health and Human Services expects to release a report in 2022 following completion of its analysis of Medicaid Managed Care Organization (MCO) PBM pricing.
Health Law Diagnosed — Key Takeaways from the 6th Annual Pharmacy & Pharmaceutical Industry Summit
April 7, 2022 | Podcast | By Stephnie John, Bridgette Keller, Hassan Shaikh
PBM Regulatory Roundup (Spring 2022): The 8th Circuit Rules and More States Issue Regulations
March 29, 2022 | Blog | By Hassan Shaikh, Bridgette Keller
CMS Proposes Changes to Part D Regulations: Pharmacy Price Concessions
January 24, 2022 | Blog | By Hassan Shaikh
Health Law Diagnosed — Mintz’s 2022 Health Law New Year’s Resolutions
January 12, 2022 | Podcast | By Bridgette Keller
News & Press
4 Pharma Industry Arguments Against CMS Drug Pricing Plan
September 29, 2023
Ask A Mentor: How Can I Successfully Switch Practices?
November 9, 2021
Publications
- Co-author, Assessing College Students' Use of Campus Recreation Facilities Through Individual and Environmental Factors, Recreational Sports Journal, (October 2018)
Involvement
- Member, American Bar Association
- Member, American Health Law Association
- Member, Health Care Compliance Association
